NLE Cardiovascular Nursing — Heart Failure and Cardiac DysrhythmiasExam Answer Templates

Marks

1

Topic

Heart Failure — Definition and Pathophysiology

Difficulty

easy

Template Id

T1

Examiner Tip

Examiners reward the phrase 'meet the metabolic demands of the body' — this is the hallmark clinical definition. One precise sentence is all you need for 1 mark.

Model Answer

Heart failure (HF) is a clinical syndrome in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body, resulting in inadequate cardiac output and/or elevated filling pressures.

Question Type

very_short_answer

Answer Structure

• Line 1: State that HF is a clinical syndrome — mention inadequate pumping and failure to meet metabolic demands [1 mark]

Scoring Breakdown

Common Mark Deductions

• Writing 'the heart is weak' without clinical specificity — too vague for a mark
• Omitting the consequence (inadequate cardiac output or elevated filling pressures)
• Confusing HF with myocardial infarction or cardiac arrest

Key Phrases To Include

• clinical syndrome
• unable to pump sufficient blood
• metabolic demands of the body
• inadequate cardiac output

Marks

1

Topic

Cardiac Pharmacology — Digoxin

Difficulty

easy

Template Id

T2

Examiner Tip

This is a classic NLE drug safety question. Examiners look for three elements: apical site, one full minute, and the 60 bpm threshold. Missing any one of these typically loses the mark.

Model Answer

The apical pulse must be counted for one full minute before each digoxin dose. If the rate is below 60 beats per minute in an adult, digoxin must be withheld and the physician notified, because digoxin slows the heart rate (negative chronotropic effect) and administering it to a bradycardic patient can cause dangerous dysrhythmias.

Question Type

very_short_answer

Answer Structure

• Line 1: State the action — apical pulse for one full minute [0.5 mark]
• Line 2: State the threshold — hold if below 60 bpm, notify physician — and give the rationale [0.5 mark]

Scoring Breakdown

Common Mark Deductions

• Saying 'check the pulse' without specifying apical site or one-full-minute duration
• Stating the wrong threshold (e.g., 'below 80 bpm' or 'below 50 bpm')
• Omitting the rationale (why it matters)

Key Phrases To Include

• apical pulse for one full minute
• below 60 beats per minute
• withhold and notify physician
• negative chronotropic effect
• bradycardia

Marks

2

Topic

Heart Failure — Left-Sided vs. Right-Sided

Difficulty

easy

Template Id

T3

Examiner Tip

Use the mnemonics 'Left = Lungs' and 'Right = Rest of the body' as organizing headers — this shows clear logical thinking and helps prevent mixing up manifestations.

Model Answer

Left-sided heart failure causes pulmonary congestion because blood backs up into the lungs. Key manifestations include dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles (rales) on auscultation, and frothy pink (blood-tinged) sputum — summarized by the mnemonic 'Left = Lungs.' Right-sided heart failure causes systemic venous congestion because blood backs up into the systemic circulation. Key manifestations include peripheral and dependent edema, jugular venous distention (JVD), hepatomegaly, ascites, and anorexia — summarized by the mnemonic 'Right = Rest of the body.'

Question Type

short_answer

Answer Structure

• Paragraph 1: Describe left-sided HF — state the mechanism (backflow into lungs) and list at least 3 specific pulmonary manifestations [1 mark]
• Paragraph 2: Describe right-sided HF — state the mechanism (backflow into systemic circulation) and list at least 3 specific systemic manifestations [1 mark]

Scoring Breakdown

Common Mark Deductions

• Mixing up manifestations (e.g., placing JVD under left-sided HF)
• Listing only symptoms without indicating which side they belong to
• Omitting the mechanism (why the symptoms occur) — examiners reward pathophysiological reasoning

Key Phrases To Include

• pulmonary congestion
• dyspnea, orthopnea, paroxysmal nocturnal dyspnea
• crackles (rales)
• frothy pink sputum
• systemic venous congestion
• peripheral and dependent edema
• jugular venous distention (JVD)
• hepatomegaly
• ascites

Marks

2

Topic

Cardiac Pharmacology — Digoxin Toxicity

Difficulty

medium

Template Id

T4

Examiner Tip

The visual disturbance (yellow-green halos) is a highly specific and NLE-favored sign — always include it. Digibind is the only correct antidote; never substitute another agent.

Model Answer

Signs of digoxin toxicity include: (1) gastrointestinal symptoms such as anorexia, nausea, and vomiting; (2) visual disturbances, classically described as yellow-green halos around lights or blurred vision; (3) bradycardia and life-threatening cardiac dysrhythmias. The therapeutic serum level of digoxin is 0.5–2 ng/mL; levels above 2 ng/mL indicate toxicity. The antidote for digoxin toxicity is digoxin immune Fab (Digibind).

Question Type

short_answer

Answer Structure

• Line 1: State at least 2 specific signs of digoxin toxicity [1 mark]
• Line 2: Name the antidote — digoxin immune Fab (Digibind) — and optionally state the toxic serum level [1 mark]

Scoring Breakdown

Common Mark Deductions

• Listing only one sign of toxicity instead of two
• Confusing digoxin toxicity signs with side effects of other cardiac drugs
• Writing 'Narcan' or 'activated charcoal' as the antidote — these are incorrect for digoxin

Key Phrases To Include

• anorexia, nausea, vomiting
• yellow-green halos
• bradycardia
• cardiac dysrhythmias
• serum level above 2 ng/mL
• digoxin immune Fab
• Digibind

Marks

3

Topic

Acute Pulmonary Edema — Nursing Management

Difficulty

medium

Template Id

T5

Examiner Tip

Examiners expect you to demonstrate clinical prioritization — position FIRST because it is immediately lifesaving and requires no order. Then oxygen, then medications. This sequence reflects the nursing process and Maslow's hierarchy in action.

Model Answer

Acute pulmonary edema is a medical emergency caused by rapid accumulation of fluid in the alveoli, most commonly from acute decompensated left-sided heart failure. The priority nursing interventions follow the mnemonic 'LMNOP': 1. POSITION: Immediately place the patient in High Fowler's position (90°) with legs dependent. This reduces venous return (preload) and lowers the work of breathing, directly addressing 'Impaired Gas Exchange' — the priority nursing diagnosis under Maslow's physiological hierarchy. 2. OXYGEN: Administer supplemental oxygen at the prescribed rate; prepare for possible noninvasive positive pressure ventilation (BiPAP/CPAP) if hypoxia is severe. Monitor oxygen saturation continuously. 3. MEDICATIONS: Administer IV loop diuretic (furosemide) as ordered to promote rapid diuresis and reduce fluid overload. Morphine may be given to reduce anxiety, decrease preload, and ease the work of breathing. Nitrates may be prescribed to reduce preload and afterload. 4. MONITOR: Continuously monitor vital signs, oxygen saturation, respiratory rate and effort, lung sounds, and urine output (strict intake and output). Report any deterioration immediately. These interventions are grounded in Maslow's physiological priority — airway and oxygenation are addressed before all other concerns.

Question Type

short_answer

Answer Structure

• Opening sentence: Identify acute pulmonary edema as a medical emergency and state its cause [sets context]
• Point 1: High Fowler's position with legs dependent — state rationale (reduces preload, improves breathing) and link to nursing diagnosis [1 mark]
• Point 2: Oxygen administration and monitoring [0.5 mark]
• Point 3: Medications — IV furosemide, morphine, nitrates [1 mark]
• Point 4: Continuous monitoring — vital signs, O2 sat, lung sounds, I&O [0.5 mark]

Scoring Breakdown

Common Mark Deductions

• Stating 'supine position' or 'flat position' — this is dangerous and wrong for pulmonary edema
• Listing medications without rationale — examiners expect you to explain WHY each drug is given
• Omitting positioning as the first intervention — this is the highest priority and must come first
• Using vague language like 'monitor the patient' without specifying what to monitor

Key Phrases To Include

• High Fowler's position with legs dependent
• reduces venous return (preload)
• Impaired Gas Exchange
• IV furosemide (loop diuretic)
• morphine to reduce anxiety and preload
• nitrates to reduce preload and afterload
• supplemental oxygen
• continuous monitoring
• intake and output
• medical emergency

Marks

3

Topic

Cardiac Dysrhythmias — Electrical Therapies

Difficulty

medium

Template Id

T6

Examiner Tip

The key distinguishing phrase for cardioversion is 'synchronized to the R wave to avoid the T wave (vulnerable period)' — this demonstrates pathophysiological understanding and earns extra credit in most rubrics.

Model Answer

Defibrillation and synchronized cardioversion are both electrical therapies but differ in indication, timing, and synchronization setting: DEFIBRILLATION is an unsynchronized electrical shock delivered immediately without regard to the cardiac cycle. It is the treatment of choice for pulseless ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT) — both lethal arrest rhythms. The nurse's role is to call a Code Blue, initiate CPR immediately, prepare the defibrillator, ensure all personnel stand clear ('All clear!'), and document the time, energy level, and patient response. There is no time to obtain consent in a cardiac arrest. SYNCHRONIZED CARDIOVERSION delivers a shock timed to the R wave of the QRS complex to avoid triggering VF by hitting the T wave (the vulnerable period). It is used for unstable but perfusing dysrhythmias such as atrial fibrillation with rapid ventricular response, atrial flutter, or stable VT with a pulse. The nurse's role includes obtaining informed consent if the patient is conscious, sedating the patient as ordered, setting the defibrillator to 'synchronized' mode, and monitoring for rhythm conversion and hemodynamic stability afterward.

Question Type

short_answer

Answer Structure

• Opening sentence: State that both are electrical therapies but differ in key features
• Paragraph 1: Defibrillation — define as unsynchronized, state indications (VF, pulseless VT), and describe nursing role [1.5 marks]
• Paragraph 2: Synchronized cardioversion — define as synchronized to R wave, state indications (unstable AFib, stable VT with pulse), and describe nursing role [1.5 marks]

Scoring Breakdown

Common Mark Deductions

• Reversing the indications — stating that defibrillation is used for AFib or that cardioversion is for VF
• Omitting the synchronization rationale (avoiding the T wave) — this is what earns the 'understanding' mark
• Failing to mention the nursing role for each procedure
• Stating that consent is needed for defibrillation in a cardiac arrest — in an emergency, implied consent applies

Key Phrases To Include

• unsynchronized shock
• ventricular fibrillation (VF)
• pulseless ventricular tachycardia
• cardiac arrest
• synchronized to the R wave
• avoid the T wave (vulnerable period)
• unstable atrial fibrillation
• stable VT with a pulse
• synchronized mode
• informed consent
• sedation

Marks

5

Topic

Chronic Heart Failure — Comprehensive Nursing Management

Difficulty

hard

Template Id

T7

Examiner Tip

For 5-mark questions, examiners use a detailed rubric. Every section of the nursing process (assessment, diagnosis, planning, intervention, evaluation) should have at least one specific point. Using subheadings (Roman numerals or bold headings) makes your answer easier for the examiner to score and signals organizational competence. Always include at least one Philippine healthcare context reference for top marks.

Model Answer

CHRONIC HEART FAILURE: NURSING MANAGEMENT AND PATIENT TEACHING I. DEFINITION AND CONTEXT Heart failure (HF) is a chronic clinical syndrome in which the heart cannot maintain adequate cardiac output to meet the body's metabolic demands. In the Philippine context, HF is often a complication of poorly controlled hypertension and coronary artery disease — both of which are addressed by the DOH PhilPEN (Philippine Package of Essential NCD Interventions) program at the primary care level. II. NURSING ASSESSMENTS The nurse performs a systematic assessment guided by the NANDA nursing diagnosis framework: - Respiratory: Auscultate lung sounds for crackles (rales) indicating pulmonary congestion; assess for dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. - Cardiovascular: Monitor vital signs, heart sounds (S3 gallop indicates ventricular failure), and oxygen saturation. - Fluid status: Assess for peripheral and dependent edema, jugular venous distention (JVD), ascites, and daily weight. A weight gain of 1 kg (approximately 2 lb) in a day or 2.5 kg in a week signals fluid retention and must be reported. - Diagnostics: Monitor BNP levels (normal below 100 pg/mL; elevated levels correlate with HF severity) and review echocardiogram results for ejection fraction (normal 55–70%; reduced in systolic HF). III. PRIORITY NURSING DIAGNOSES (NANDA) 1. Decreased Cardiac Output related to impaired myocardial contractility — priority 1 (Maslow: physiological) 2. Excess Fluid Volume related to compromised regulatory mechanisms — priority 2 (Maslow: physiological) 3. Impaired Gas Exchange related to alveolar-capillary membrane changes — priority 3 4. Activity Intolerance related to imbalance between oxygen supply and demand 5. Deficient Knowledge related to HF self-management regimen IV. NURSING INTERVENTIONS - Position: Maintain semi- to high-Fowler's position to ease breathing and reduce venous return. - Fluid and Sodium Restriction: Implement prescribed fluid (usually 1.5–2 L/day) and sodium restrictions to minimize fluid retention. - Medication Administration: Administer medications as ordered — ACE inhibitors (enalapril), beta-blockers (carvedilol), loop diuretics (furosemide), and digoxin — with appropriate safety checks (apical pulse before digoxin; blood pressure before beta-blockers; potassium monitoring with diuretics). - Activity: Balance activity with rest periods to reduce cardiac workload; gradually increase activity as tolerated. - Monitoring: Strict intake and output, daily weight at the same time each day on the same scale, and auscultation of breath sounds. V. PATIENT TEACHING (KEY NLE POINTS) Teach the patient and family the following: - Weigh daily at the same time each morning after voiding; report a gain of 1 kg in one day or 2.5 kg in one week to the physician immediately. - Follow sodium restriction (as prescribed) and fluid restriction — avoid canned goods and salty processed foods common in Filipino diets (e.g., bagoong, processed meats, instant noodles). - Take medications exactly as prescribed. Never skip digoxin doses or stop beta-blockers abruptly (abrupt cessation can trigger rebound tachycardia and angina). - Learn to take the pulse before digoxin — hold and call the doctor if rate is below 60 bpm. - Recognize signs of digoxin toxicity: anorexia, nausea, yellow-green visual halos — seek medical attention immediately. - Attend regular follow-up at the rural health unit (RHU) or community health center, consistent with the DOH continuum of care for NCDs. - Keep activity balanced with rest; use energy-conservation techniques for activities of daily living. VI. EVALUATION The patient demonstrates: weight within 1 kg of dry weight, absence of pulmonary crackles and peripheral edema, oxygen saturation above 95%, ability to verbalize self-monitoring techniques, and adherence to the medication regimen.

Question Type

long_answer

Answer Structure

• Part I: Brief definition and Philippine context (DOH PhilPEN reference) [0.5 mark]
• Part II: Systematic nursing assessment — respiratory, cardiovascular, fluid status, diagnostics (BNP, ejection fraction) [1 mark]
• Part III: NANDA nursing diagnoses — at least 3 prioritized using Maslow [0.5 mark]
• Part IV: Nursing interventions — positioning, fluid/sodium restriction, medication safety, monitoring [1.5 marks]
• Part V: Patient teaching — daily weight monitoring, sodium/fluid restriction, medication adherence, pulse taking, toxicity signs [1 mark]
• Part VI: Evaluation criteria [0.5 mark]

Scoring Breakdown

Common Mark Deductions

• Writing a list of symptoms only, without framing them as assessments within the nursing process
• Omitting NANDA nursing diagnoses — these are required for 5-mark clinical management questions
• Not including the specific daily weight thresholds (1 kg/day, 2.5 kg/week) — vague answers like 'monitor for weight gain' are penalized
• Failing to mention medication safety checks (apical pulse for digoxin, potassium monitoring with diuretics) — these are classic NLE points
• Not applying Maslow's hierarchy to prioritize nursing diagnoses
• Omitting patient teaching section — for a 5-mark question, teaching is expected

Key Phrases To Include

• inadequate cardiac output
• crackles (rales) on auscultation
• jugular venous distention (JVD)
• BNP elevated above 100 pg/mL
• ejection fraction (normal 55–70%)
• Decreased Cardiac Output (NANDA)
• Excess Fluid Volume (NANDA)
• High Fowler's position
• fluid and sodium restriction
• apical pulse before digoxin
• daily weight — 1 kg/day or 2.5 kg/week threshold
• never stop beta-blockers abruptly
• yellow-green visual halos (digoxin toxicity)
• DOH PhilPEN program
• Maslow's physiological hierarchy

Marks

1

Topic

Heart Failure — Diagnostics

Difficulty

easy

Template Id

T8

Examiner Tip

The two key facts examiners want: (1) BNP is released by ventricles under stress, and (2) levels above 100 pg/mL indicate HF. Remembering the number 100 as the threshold is a quick NLE win.

Model Answer

BNP (B-type natriuretic peptide) is a hormone released by the ventricular myocardium in response to increased wall stress and volume overload. In heart failure, BNP levels are elevated above 100 pg/mL and correlate directly with the severity of HF. It is used as both a diagnostic marker and a measure of treatment response.

Question Type

very_short_answer

Answer Structure

• Line 1: Define BNP and state its source (ventricular myocardium under stress) [0.5 mark]
• Line 2: State the significance — elevated in HF (above 100 pg/mL), correlates with severity [0.5 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing BNP with troponin (troponin is a marker for myocardial injury/infarction, not HF severity)
• Not stating the normal/abnormal threshold (100 pg/mL)
• Defining BNP without explaining its clinical relevance to HF

Key Phrases To Include

• B-type natriuretic peptide
• ventricular myocardium
• increased wall stress
• above 100 pg/mL
• severity of heart failure
• diagnostic marker

Marks

3

Topic

Cardiac Dysrhythmias — Atrial Fibrillation

Difficulty

medium

Template Id

T9

Examiner Tip

The phrase 'irregularly irregular with absent P waves' is the signature ECG description of AFib — examiners consider this essential. The stroke risk mechanism (stasis → thrombus → embolism) is what elevates a 2-mark answer to a 3-mark answer.

Model Answer

ATRIAL FIBRILLATION (AFib): Atrial fibrillation is the most common chronic cardiac dysrhythmia, characterized by chaotic, disorganized electrical activity in the atria. It is caused by multiple re-entrant electrical circuits firing simultaneously in the atria. ECG CHARACTERISTICS: - Irregularly irregular ventricular rhythm (completely unpredictable R-R intervals) - Absence of distinct P waves (replaced by chaotic fibrillatory baseline) - Ventricular rate varies and may be rapid (100–160 bpm in uncontrolled AFib) or controlled - QRS complexes are typically narrow (unless aberrant conduction is present) RATIONALE FOR ANTICOAGULATION: In AFib, the atria do not contract effectively — they quiver instead. This loss of the atrial 'kick' causes blood to pool and stagnate in the atrial chambers, particularly the left atrial appendage. Stasis of blood leads to thrombus (clot) formation. If a clot dislodges, it becomes an embolus that can travel to the cerebral circulation and cause an ischemic stroke. Therefore, anticoagulation therapy — using warfarin (monitoring INR to a target of 2–3) or a direct oral anticoagulant (DOAC) such as rivaroxaban — is essential to prevent thromboembolic stroke. Nurses must teach patients on anticoagulants to follow bleeding precautions and attend INR monitoring as prescribed.

Question Type

short_answer

Answer Structure

• Paragraph 1: Define AFib — chaotic atrial electrical activity, most common chronic dysrhythmia [0.5 mark]
• Paragraph 2: ECG characteristics — 4 features: irregularly irregular rhythm, absent P waves, variable ventricular rate, narrow QRS [1 mark]
• Paragraph 3: Rationale for anticoagulation — mechanism (no effective atrial contraction → stasis → thrombus → embolic stroke) and specific drugs mentioned [1.5 marks]

Scoring Breakdown

Common Mark Deductions

• Describing AFib as 'regularly irregular' — it is IRREGULARLY irregular (completely unpredictable)
• Stating that P waves are present but abnormal — in AFib, P waves are ABSENT
• Omitting the mechanism of stroke risk (stasis → thrombus → embolism) and stating only that 'anticoagulants prevent clots' without pathophysiological reasoning
• Confusing AFib with atrial flutter (flutter has a 'sawtooth' pattern and regular atrial activity)

Key Phrases To Include

• irregularly irregular ventricular rhythm
• absent P waves
• chaotic fibrillatory baseline
• loss of atrial kick
• blood stasis in left atrial appendage
• thrombus formation
• embolic stroke
• warfarin
• INR target 2–3
• direct oral anticoagulant (DOAC)
• bleeding precautions

Marks

3

Topic

Cardiac Pharmacology — Diuretics

Difficulty

hard

Template Id

T10

Examiner Tip

This question tests both pharmacology and clinical safety reasoning. Examiners reward the specific mechanism: hypokalemia potentiates digoxin toxicity because potassium and digoxin compete for the same Na-K-ATPase receptor. This one sentence alone can earn a full mark.

Model Answer

DIURETICS AND POTASSIUM EFFECTS IN HEART FAILURE: 1. LOOP DIURETICS (e.g., furosemide): Cause HYPOKALEMIA (low serum potassium) by increasing potassium excretion in the urine. Clinical implication: In patients also taking digoxin, hypokalemia increases the risk of digoxin toxicity (potassium competes with digoxin for binding at Na-K-ATPase receptors; low potassium allows more digoxin binding, potentiating its toxic effects). Monitor serum potassium closely; administer IV furosemide slowly to also prevent ototoxicity. 2. THIAZIDE DIURETICS (e.g., hydrochlorothiazide): Also cause HYPOKALEMIA through a similar mechanism. Clinical implication: Used for mild HF and hypertension; same risk for digoxin toxicity applies. Monitor potassium and supplement as needed. 3. POTASSIUM-SPARING DIURETICS (e.g., spironolactone): Cause HYPERKALEMIA (elevated serum potassium) because they block aldosterone, preventing potassium excretion. Clinical implication: Spironolactone has proven survival benefits in HF; however, patients must avoid potassium supplements and potassium-rich salt substitutes (often used in Filipino low-sodium cooking). Risk of dangerous hyperkalemia is higher when combined with ACE inhibitors (which also retain potassium). Monitor serum potassium regularly.

Question Type

short_answer

Answer Structure

• Point 1: Loop diuretics (furosemide) → hypokalemia → potentiates digoxin toxicity [1 mark]
• Point 2: Thiazide diuretics (HCTZ) → hypokalemia → same digoxin risk [0.5 mark]
• Point 3: Potassium-sparing diuretics (spironolactone) → hyperkalemia → avoid K+ supplements, especially with ACE inhibitors [1 mark]
• Cohesive summary or clinical nursing implication for monitoring [0.5 mark]

Scoring Breakdown

Common Mark Deductions

• Reversing the effects — stating that loop diuretics cause hyperkalemia or that spironolactone causes hypokalemia
• Omitting the mechanism linking hypokalemia to digoxin toxicity
• Failing to mention the hyperkalemia risk with combined spironolactone + ACE inhibitor use
• Not including specific drug names — generic references to 'diuretics' without naming the class representatives lose marks

Key Phrases To Include

• hypokalemia
• loop diuretics — furosemide
• potentiates digoxin toxicity
• Na-K-ATPase receptor competition
• thiazide diuretics — hydrochlorothiazide
• hyperkalemia
• spironolactone — aldosterone antagonist
• avoid potassium supplements and salt substitutes
• ACE inhibitor interaction
• monitor serum potassium

Marks

3

Topic

Heart Failure — Pathophysiology and Compensatory Mechanisms

Difficulty

hard

Template Id

T11

Examiner Tip

This question tests pathophysiology depth. The phrase 'maladaptive ventricular remodeling' is a high-yield term. Connecting each mechanism to the drug class that counteracts it (beta-blockers for SNS, ACE inhibitors for RAAS, diuretics for fluid retention) demonstrates integrated pharmacology knowledge that earns top marks.

Model Answer

In early heart failure, the body activates the following compensatory mechanisms to maintain cardiac output: 1. SYMPATHETIC NERVOUS SYSTEM ACTIVATION: Increased catecholamine release raises the heart rate (positive chronotropism) and myocardial contractility (positive inotropism). Initially helpful, but over time, persistent tachycardia increases myocardial oxygen demand, promotes ventricular remodeling, and leads to cardiomyocyte death — worsening failure. 2. RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) ACTIVATION: Reduced renal perfusion triggers renin release, leading to angiotensin II production and aldosterone secretion. This causes sodium and water retention, increasing preload and blood volume. Over time, this fluid overload increases cardiac workload, causes pulmonary and systemic congestion, and worsens both left- and right-sided HF — the basis for using ACE inhibitors and ARBs to block this system. 3. VENTRICULAR HYPERTROPHY AND DILATION: The ventricle hypertrophies (muscle thickening) to increase contractile force and dilates to accommodate increased volume. Initially this maintains stroke volume; however, over time, hypertrophy impairs diastolic relaxation and increases afterload, while dilation stretches and eventually weakens the myocardium — a process called maladaptive ventricular remodeling. These mechanisms are the pharmacological targets in HF: beta-blockers block SNS overactivation, ACE inhibitors/ARBs block RAAS, and diuretics counteract fluid retention.

Question Type

short_answer

Answer Structure

• Point 1: SNS activation — describe mechanism AND explain why it becomes harmful [1 mark]
• Point 2: RAAS activation — describe mechanism AND explain why it becomes harmful [1 mark]
• Point 3: Ventricular hypertrophy/dilation — describe mechanism AND explain why it becomes harmful [1 mark]

Scoring Breakdown

Common Mark Deductions

• Describing only the initial helpful effects without explaining how they become harmful — this is the core of the question
• Listing mechanisms without adequate explanation — a list without pathophysiological reasoning earns half marks at best
• Confusing hypertrophy (thickening) with dilation (enlargement) — they are different processes

Key Phrases To Include

• sympathetic nervous system
• increased heart rate and contractility
• increased myocardial oxygen demand
• renin-angiotensin-aldosterone system (RAAS)
• sodium and water retention
• increased preload
• fluid overload
• ventricular hypertrophy
• ventricular dilation
• maladaptive ventricular remodeling
• basis for ACE inhibitors and beta-blockers

Marks

2

Topic

Pacemakers — Nursing Management

Difficulty

medium

Template Id

T12

Examiner Tip

Define 'failure to capture' precisely — it is the most NLE-tested pacemaker complication. Saying 'a pacing spike NOT followed by a QRS complex' demonstrates technical understanding that distinguishes a top answer.

Model Answer

Nursing responsibilities for a patient with a permanent cardiac pacemaker include: 1. ECG MONITORING: Monitor the ECG for proper pacemaker function. Recognize 'failure to capture' (a pacing spike NOT followed by a QRS complex, indicating the stimulus failed to depolarize the ventricle) and 'failure to sense' (the pacemaker fires when it should not, because it cannot detect the patient's own beats). Report abnormalities immediately. 2. POST-IMPLANTATION CARE: After implantation, restrict movement of the affected arm (usually left) to prevent lead dislodgement. Teach the patient to avoid lifting the arm above shoulder height until the leads are secured (typically 4–6 weeks). Assess the implantation site for signs of infection (redness, swelling, discharge). 3. PATIENT TEACHING: Instruct the patient to: check the pulse daily and report a rate below the pacemaker's set rate, carry a pacemaker identification card at all times, avoid strong electromagnetic fields (MRI unless MRI-conditional device, arc welding), and understand that most household appliances and mobile phones are safe when kept a short distance from the device.

Question Type

short_answer

Answer Structure

• Point 1: ECG monitoring — failure to capture and failure to sense [0.5 mark]
• Point 2: Post-implantation site care and arm restriction [0.5 mark]
• Point 3: Patient teaching — pulse check, ID card, electromagnetic precautions [1 mark]

Scoring Breakdown

Common Mark Deductions

• Vague responses like 'monitor the patient' without specifying what pacemaker-specific complications to watch for
• Omitting the definition of failure to capture (a very common NLE question point)
• Stating that all MRI is contraindicated — modern MRI-conditional pacemakers exist; this blanket statement is partially incorrect

Key Phrases To Include

• failure to capture
• pacing spike not followed by QRS
• failure to sense
• restrict movement of affected arm
• lead dislodgement
• check pulse daily
• pacemaker identification card
• avoid strong electromagnetic fields
• MRI restriction unless MRI-conditional

Marks

2

Topic

Cardiac Dysrhythmias — Ventricular Fibrillation and Cardiac Arrest

Difficulty

medium

Template Id

T13

Examiner Tip

For any cardiac arrest scenario, remember the sequence: Assess → Call for help (Code Blue) → CPR → Defibrillate for shockable rhythms. The distinction between shockable (VF, pulseless VT → defibrillate) and non-shockable (asystole, PEA → CPR + epinephrine only) is a classic NLE discriminator.

Model Answer

IMMEDIATE PRIORITY: Initiate CPR (cardiopulmonary resuscitation) and prepare for immediate DEFIBRILLATION. Priority Action: The nurse must immediately call for help (activate Code Blue per hospital protocol — as guided by the Philippine nurse's scope of practice under RA 9173), initiate high-quality CPR (30 compressions : 2 breaths cycle, or continuous compressions if advanced airway is in place), and prepare the defibrillator for unsynchronized defibrillation. Defibrillation is delivered as soon as the device is charged — every minute without defibrillation in VF reduces the chance of survival by approximately 7–10%. RATIONALE: Ventricular fibrillation (VF) is a lethal, shockable cardiac arrest rhythm characterized by chaotic, disorganized electrical activity in the ventricles with NO effective cardiac output. There is no pulse, no blood pressure, and no tissue perfusion. CPR maintains minimal perfusion to the brain and heart until defibrillation can terminate the VF and allow the heart's natural pacemaker to resume a perfusing rhythm. Defibrillation is the ONLY definitive treatment for VF — it delivers an unsynchronized electrical shock that depolarizes the entire myocardium simultaneously, allowing the sinoatrial node to re-establish organized electrical activity.

Question Type

case_study

Answer Structure

• Line 1: State the immediate action — CPR AND defibrillation (both must be mentioned) [1 mark]
• Line 2: Provide the rationale — VF is a shockable lethal arrest rhythm with no cardiac output; CPR maintains perfusion; defibrillation is the only definitive treatment [1 mark]

Scoring Breakdown

Common Mark Deductions

• Stating synchronized cardioversion instead of unsynchronized defibrillation — VF is pulseless and cannot be synchronized
• Mentioning only CPR without defibrillation — CPR alone does NOT convert VF
• Stating 'administer epinephrine' as the first action — epinephrine is given after the first defibrillation attempt, not first
• Omitting the rationale — for 2-mark case questions, the 'why' is always worth a mark

Key Phrases To Include

• Code Blue
• CPR — 30 compressions to 2 breaths
• unsynchronized defibrillation
• shockable rhythm
• no effective cardiac output
• chaotic ventricular electrical activity
• depolarizes the entire myocardium
• sinoatrial node to resume organized activity
• RA 9173 scope of nursing practice

Marks

5

Topic

Cardiac Pharmacology — ACE Inhibitors and Beta-Blockers in HF

Difficulty

hard

Template Id

T14

Examiner Tip

For 5-mark pharmacology questions, organize by drug class with clear subheadings. Examiners marking with a rubric will look for: mechanism → clinical use → nursing monitoring → patient teaching → Philippine context. This structure ensures you hit every marking criterion systematically. The 'never stop beta-blockers abruptly' instruction earns a dedicated half-mark in most rubrics.

Model Answer

PHARMACOLOGICAL MANAGEMENT OF HEART FAILURE: ACE INHIBITORS AND BETA-BLOCKERS I. OVERVIEW The cornerstone of evidence-based pharmacological management of chronic HF with reduced ejection fraction (HFrEF) includes neurohormonal blockade using ACE inhibitors (or ARBs) and beta-blockers. Both drug classes reduce mortality and morbidity by blocking the maladaptive compensatory responses (RAAS and SNS respectively) that worsen cardiac remodeling over time. II. ACE INHIBITORS (e.g., enalapril, lisinopril, captopril) MECHANISM OF ACTION: ACE inhibitors block angiotensin-converting enzyme (ACE), preventing the conversion of angiotensin I to angiotensin II. The result is: - Vasodilation (reduced afterload) — easing the workload on the failing left ventricle - Reduced aldosterone secretion — decreasing sodium and water retention (reduced preload) - Slowing of maladaptive ventricular remodeling CLINICAL USES IN HF: First-line therapy for systolic HF (reduced ejection fraction); also used in hypertension and post-MI ventricular dysfunction. NURSING CONSIDERATIONS: - Monitor blood pressure before each dose; withhold and report if hypotension is present (systolic BP below the prescribed parameter, typically 90 mmHg). First-dose hypotension is common. - Monitor serum potassium — ACE inhibitors cause potassium retention (hyperkalemia risk), especially when combined with potassium-sparing diuretics. - Assess for the hallmark side effect: a persistent, dry, non-productive cough (caused by accumulation of bradykinin). If the patient cannot tolerate the cough, an ARB (e.g., losartan, valsartan) is prescribed instead. - Monitor for angioedema (swelling of face, lips, tongue, or throat) — a rare but life-threatening reaction requiring immediate drug discontinuation and emergency care. - Monitor renal function (BUN, creatinine) — ACE inhibitors can reduce glomerular filtration in patients with bilateral renal artery stenosis. - Teach patients to avoid NSAIDS and potassium supplements; rise slowly from sitting/lying to prevent orthostatic hypotension. III. BETA-BLOCKERS (e.g., carvedilol, metoprolol succinate, bisoprolol) MECHANISM OF ACTION: Beta-blockers competitively block beta-1 (and beta-2 in non-selective agents) adrenergic receptors, counteracting the harmful effects of chronic SNS overactivation in HF: - Reduced heart rate (negative chronotropic effect) - Reduced myocardial oxygen demand - Prevention of catecholamine-induced myocardial damage and arrhythmias - Long-term reversal of ventricular remodeling CLINICAL USES IN HF: Essential for chronic HF management — proven to reduce sudden cardiac death by up to 34%. Always started at low doses and titrated slowly (never started during acute decompensation or when the patient is fluid-overloaded). NURSING CONSIDERATIONS: - Monitor heart rate and blood pressure before each dose. HOLD if the heart rate is below 60 bpm or if systolic BP is below the prescribed threshold (usually 90 mmHg); notify the physician. - NEVER stop beta-blockers abruptly — abrupt discontinuation causes rebound tachycardia, hypertension, and can precipitate angina or acute MI (especially in patients with coronary artery disease). - Monitor for signs of worsening HF (weight gain, increased dyspnea, peripheral edema) when initiating therapy, as beta-blockers transiently depress contractility. - Caution in patients with asthma or COPD — beta-2 blockade can cause bronchospasm; use cardioselective beta-1 blockers (metoprolol, bisoprolol) and monitor respiratory status closely. - Teach patients to take the pulse before each dose and to report dizziness or unusual fatigue. IV. MONITORING PARAMETERS SUMMARY - Before every dose: check apical pulse (hold if below 60 bpm) for both beta-blockers and digoxin; check BP for ACE inhibitors and beta-blockers. - Laboratory: serum potassium (hypo risk with diuretics; hyper risk with ACE inhibitors + spironolactone), renal function, and BNP for therapeutic response. V. PHILIPPINE HEALTHCARE CONTEXT Under RA 9173 (Philippine Nursing Act of 2002), nurses are responsible for the safe administration of medications, which includes pre-administration assessment and correct documentation. The DOH PhilPEN program promotes hypertension control at the primary care level to prevent HF progression. Nurses at the rural health unit (RHU) play a critical role in medication adherence counseling for HF patients on these long-term drug regimens.

Question Type

long_answer

Answer Structure

• Section I: Brief overview — neurohormonal blockade concept [0.5 mark]
• Section II ACE Inhibitors: Mechanism of action (RAAS blockade → reduced afterload and preload, prevent remodeling) [1 mark]
• Section II ACE Inhibitors continued: Nursing considerations — hypotension (first-dose), hyperkalemia, dry cough, angioedema, renal monitoring [1 mark]
• Section III Beta-Blockers: Mechanism of action (SNS blockade → reduced HR, O2 demand, remodeling) [0.5 mark]
• Section III Beta-Blockers continued: Nursing considerations — pulse/BP check, no abrupt stop, bronchospasm caution, worsening HF on initiation [1 mark]
• Section IV-V: Monitoring parameters summary and Philippine context (RA 9173, DOH PhilPEN, RHU) [1 mark]

Scoring Breakdown

Common Mark Deductions

• Describing mechanisms as 'lowers blood pressure' without explaining HOW (RAAS or SNS blockade) — this lacks depth
• Omitting the 'never stop beta-blockers abruptly' instruction — this is a classic NLE patient safety point
• Not differentiating the dry cough (ACE inhibitor) from angioedema (both ACE inhibitor, but different severity and management)
• Failing to mention that beta-blockers are started slowly and not during acute decompensation
• Omitting Philippine nursing law or healthcare context in a 5-mark comprehensive answer

Key Phrases To Include

• ACE inhibitor — blocks angiotensin-converting enzyme
• reduced afterload and preload
• ventricular remodeling
• first-dose hypotension
• hyperkalemia
• persistent dry non-productive cough
• angioedema — life-threatening
• ARB alternative (losartan, valsartan)
• beta-blocker — carvedilol, metoprolol, bisoprolol
• negative chronotropic effect
• NEVER stop abruptly
• rebound tachycardia
• bronchospasm in asthma/COPD
• hold if heart rate below 60 bpm
• RA 9173
• DOH PhilPEN program

Marks

1

Topic

Pacemakers — Complications

Difficulty

medium

Template Id

T15

Examiner Tip

The distinction between 'failure to capture' (spike present, no QRS after) and 'failure to sense' (pacemaker fires inappropriately because it does not detect native beats) is a highly specific NLE point. Always define both if asked about pacemaker complications.

Model Answer

Failure to capture is a pacemaker malfunction in which a pacing spike (electrical stimulus) is visible on the ECG but is NOT followed by a QRS complex (in ventricular pacing) or a P wave (in atrial pacing), indicating that the electrical stimulus failed to depolarize the myocardium and initiate a mechanical contraction.

Question Type

very_short_answer

Answer Structure

• Line 1: Define failure to capture as a pacemaker malfunction — pacing spike visible but not followed by QRS/P wave [1 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing failure to capture with failure to sense (failure to sense = pacemaker fires when it should not because it cannot detect the patient's own beats)
• Saying 'no pacing spike' — in failure to capture, the spike IS present; the problem is that it fails to produce a response
• Vague definition without mentioning the ECG appearance (pacing spike without QRS)

Key Phrases To Include

• pacing spike
• NOT followed by QRS complex
• failed to depolarize the myocardium
• pacemaker malfunction